Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Intelligent Bio Solutions Inc INBS

Intelligent Bio Solutions Inc. is a life sciences company. The Company is engaged in developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It operates through two segments, namely Commercially available Intelligent Fingerprinting Products (IFPG) and Development Stage Saliva Glucose Biosensor Platform (SGBP). Its product portfolio includes a portable drug screening system that works by analyzing fingerprint sweat using a one-time cartridge and portable handheld reader and also includes a development stage range of biosensor- based Point of Care diagnostic tests (POCT) that are developed in the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology. Its product candidate is the Saliva Glucose Biosensor (SGB), a POCT expected to substitute the finger pricking invasive blood glucose monitoring for diabetic patients. Its Biosensor Platform helps to detect multiple biological analytes.


NDAQ:INBS - Post by User

Post by AveragePennyon Mar 01, 2024 9:48am
28 Views
Post# 35908834

Intelligent Bio Solutions Inc. to Present at the Emerging

Intelligent Bio Solutions Inc. to Present at the Emerging

NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it will present at the Emerging Growth Conference on March 6, 2024. INBS will provide an update on the Company’s growth and financial performance in 2023, among other topics.

Spiro Sakiris, INBS’ Chief Financial Officer, is scheduled to present from 3:40 p.m. to 3:50 p.m. Eastern Time on Wednesday, March 6, 2024.

Link to register: https://goto.webcasts.com/starthere.jsp?ei=1650531&tp_key=ca9510e531&sti=inbs

Following the event, an archived webcast will be available on emerginggrowth.com and the Emerging Growth YouTube Channel: https://www.YouTube.com/EmergingGrowthConference. A link to the webcast will be released after the event for convenient access.

Attendees are encouraged to submit their questions in advance to Questions@EmergingGrowth.com or ask questions throughout the event.

 

https://www.globenewswire.com/news-release/2024/03/01/2838810/0/en/Intelligent-Bio-Solutions-Inc-to-Present-at-the-Emerging-Growth-Conference-on-March-6-2024.html

<< Previous
Bullboard Posts
Next >>